Sunsyn Analyticals: Taking India's Laboratory Supply Expertise to Global Pharma Markets

Govardhan Reddy Jaggavarapu, Partner

Govardhan Reddy Jaggavarapu

Partner

Pharmaceutical laboratories operate in an environ­ment where precision is inseparable from produc­tivity. From volumetric glassware used in routine quality control to filtration products, chromatography consumables and specialised analytical accessories, lab­oratories depend on products that perform consistently and arrive when required.

As analytical practices become more sophisticated, suppliers are consequently expected to understand applications, specifications and procure­ment challenges rather than merely provide an extensive catalogue.

SUNSYN Analyticals is building its position around this requirement. Established in 2018, the company sup­plies pharmaceutical, research and educational institu­tions with precision laboratory glassware, plasticware, PMP ware for ICP/IC analysis, filter papers, syringe filters, benchtop instruments, syringes, HPLC/GC columns and accessories, general consumables and impurity standards. Alongside its domestic presence, the company has devel­oped an expanding export business, particularly in labo­ratory glassware.

Driving this growth is Govardhan Reddy Jaggavarapu, Partner, whose career combines hands-on pharmaceutical Quality Control experience with laboratory product marketing. A B.Sc. graduate, Govardhan worked with Hetero Pharmaceuticals, Smruthi Organics and Piramal Healthcare before moving into marketing with Borosil Glass Works.

This progression from using laboratory products to understanding their commercial requirements has given him a practical perspective on what customers expect from a supplier.

A Portfolio Shaped at the QC Bench

SUNSYN’s product portfolio has been built around the realities of pharmaceutical laboratories. Govardhan’s earlier experience in Quality Control exposed him directly to glassware, analytical instruments and consumables used in everyday laboratory workflows. His subsequent experience in marketing helped him understand the other side of the equation - product availability, customer expectations and supplier relationships.

“My experience in both Quality Control and marketing helps me understand products from the laboratory user’s perspective. I have worked with many of these glassware products, instruments and consumables myself, so understanding customer requirements comes naturally”, says Govardhan Reddy Jaggavarapu, Partner.

This background allows the company to engage with customers beyond catalogue-based selling. Its network of pharmaceutical professionals, former colleagues and customers also provides continuous visibility into changing laboratory requirements.

SUNSYN sees particular value in identifying modifications that can improve usability. Laboratories sometimes continue using the same product configuration for years, even when relatively minor changes could simplify an application. The company therefore works with customers to identify customised glassware and related products where appropriate.

SUNSYN has consequently focused on developing packaging and shipment practices aimed at minimizing breakage across longdistance deliveries

Govardhan Reddy Jaggavarapu, Partner

Selecting for Reliability, Not Just Range

As a trading and distribution company rather than a manufacturer, SUNSYN takes a clear position on its role in the quality chain. Its responsibility is to identify manufacturers and products that demonstrate reliability, appropriate quality and sustained acceptance among laboratory users.

Customer experience is an important part of this selection process. Instead of claiming manufacturing control, SUNSYN evaluates how particular makes and products perform in the market and whether customers continue to accept them for their intended applications.

This approach is especially relevant across a portfolio ranging from laboratory glassware and filtration products to chromatography accessories and specialised consumables. By combining product familiarity with customer feedback, the company seeks to match laboratory requirements with dependable solutions.

“Our focus is on supplying products that have demonstrated good market acceptance and reliability. Ultimately, the product has to work appropriately for the customer’s application, and that remains central to our selection”, Govardhan explains.

Building an Export Model Around Execution

SUNSYN entered the export market in 2019, with the U.S. emerging as an important destination. According to the company, based on EXIM trade data, SUNSYN Analyticals ranks as the third-largest exporter of laboratory glassware from India to the U.S. Behind that achievement lies a demanding logistics operation.

Glassware is inherently vulnerable during transportation, making packaging a critical part of international fulfilment. The firm has consequently focused on developing packaging and shipment practices aimed at minimising breakage across long-distance deliveries.

The company also manages DDP shipments, supporting movement from its end through to the customer’s location. International fulfilment can involve customs procedures, documentation requirements and occasional examination of shipments by U.S. FDA authorities. When questions arise or consignments are held, SUNSYN’s team coordinates responses and provides the necessary information to facilitate clearance.

For day-to-day operations, the company maintains controlled inventory levels and uses software for stock visibility, invoicing and business records. Technology is employed selectively, with the objective of keeping procurement and fulfilment straightforward and dependable.

Creating a Wider International Footprint

International expansion now forms the centrepiece of SUNSYN’s next growth phase. The company has established entities in the UK and the U.S. and is conducting business across markets including Australia, Ireland, the UK and the U.S. It is also exploring opportunities across the Middle East and Europe, with Saudi Arabia and Germany among its priorities.

Portfolio expansion will accompany this geographical growth. Beyond laboratory glassware and consumables, the firm intends to strengthen its presence in chemicals and pharmaceutical excipients, opening another avenue within pharmaceutical manufacturing supply chains.

“Our vision is to establish SUNSYN across the major pharmaceutical markets of the world. Along with expanding geographically, we want to broaden our portfolio into chemicals and excipients while continuing to strengthen the service and reliability our customers expect,” concludes Govardhan.

For SUNSYN, therefore, global expansion is not a departure from its original proposition but an extension of it: applying laboratory understanding, careful product selection and hands-on execution to serve a progressively wider pharmaceutical customer base.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.